Although 22.1% of placebo patients achieved remission, significantly higher percentages of the other groups achieved remission. In the group that received 2.4 g/d of MMX mesalazine 40.5% achieved remission OR 2.4, p = 0.01 and in the group that received 4.8 g/d, 41.2% achieved remission OR 2.5, p = 0.007 Figure 3.
El 22,1% de los pacientes con placebo alcanzaron la remisión frente a los porcentajes significativamente mayores obtenido con mesalazina-MMX 2,4 g/día 40,5%; OR 2,4; p=0,01 y 4,8 g/día 41,2%; OR 2,5; p=0,007 figura 3.